Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Gresle

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|March 21, 2017
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapiesAi-Lan Nguyen, Melissa Gresle, Tessa Marshall, et al.
British Journal of Pharmacology|July 16, 2020
Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosisWei Zhen Yeh, Melissa Gresle, Vilija Jokubaitis, et al.
Pharmacology & Therapeutics|February 4, 2010
Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decadeAnneke Van der Walt, Helmut Butzkueven, Scott Kolbe, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Smartphone monitoring of cognition in people with multiple sclerosis: A systematic reviewYi Chao Foong, Francesca Bridge, Daniel Merlo, et al.
Scientific Reports|January 16, 2024
Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosisWei Z Yeh, Rodney Lea, Jim Stankovich, et al.
Neuroimage|August 11, 2007
MR diffusion changes correlate with ultra-structurally defined axonal degeneration in murine optic nerveQizhu Wu, Helmut Butzkueven, Melissa Gresle, et al.
Plos One|June 13, 2015
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene FunctionJudith Field, Fernando Shahijanian, Stephen Schibeci, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive testsDaniel Merlo, Tomas Kalincik, Chao Zhu, et al.
The Journal of Clinical Investigation|October 21, 2014
Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammationAnna Jonas, Stefan Thiem, Tanja Kuhlmann, et al.
Neurology|September 24, 2021
Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple SclerosisDaniel Merlo, Jim Stankovich, Claire Bai, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|March 21, 2017
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapiesAi-Lan Nguyen, Melissa Gresle, Tessa Marshall, et al.
British Journal of Pharmacology|July 16, 2020
Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosisWei Zhen Yeh, Melissa Gresle, Vilija Jokubaitis, et al.
Pharmacology & Therapeutics|February 4, 2010
Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decadeAnneke Van der Walt, Helmut Butzkueven, Scott Kolbe, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Smartphone monitoring of cognition in people with multiple sclerosis: A systematic reviewYi Chao Foong, Francesca Bridge, Daniel Merlo, et al.
Scientific Reports|January 16, 2024
Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosisWei Z Yeh, Rodney Lea, Jim Stankovich, et al.
Neuroimage|August 11, 2007
MR diffusion changes correlate with ultra-structurally defined axonal degeneration in murine optic nerveQizhu Wu, Helmut Butzkueven, Melissa Gresle, et al.
Plos One|June 13, 2015
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene FunctionJudith Field, Fernando Shahijanian, Stephen Schibeci, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive testsDaniel Merlo, Tomas Kalincik, Chao Zhu, et al.
The Journal of Clinical Investigation|October 21, 2014
Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammationAnna Jonas, Stefan Thiem, Tanja Kuhlmann, et al.
Neurology|September 24, 2021
Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple SclerosisDaniel Merlo, Jim Stankovich, Claire Bai, et al.
Pageof 3